About Acolyte Biomedica
Acolyte Biomedica is a Healthcare company based in Salisbury (United Kingdom) founded in 2000, and was acquired by 3M in February 2007. Developer of diagnostic systems for the detection of infections. The company has 16 employees. Acolyte Biomedica offers products and services including BacLite Technology and BacLite MRSA. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified. Its legal entity is Acolyte Biomedica Limited.
Company details
Acolyte Biomedica was established in 2000 and is headquartered in Salisbury, United Kingdom. Focus is placed on the biomedical sector, where diagnostic systems for identifying infections are created. Proprietary BacLite technology is utilized to enable antibiotic susceptibility testing and micro-organism identification directly from clinical samples. Operations center on advancing infectious disease diagnostics to support clinical decision-making in healthcare settings.
- Headquarters Salisbury, United Kingdom
- Employees 16
- Stage Acquired
- SectorsHealthcare
- Website acolytebiomedica.com
- Acquired by 3M (Feb 2007)
- Legal Name Acolyte Biomedica Limited
Products & Services of Acolyte Biomedica
Acolyte Biomedica offers a comprehensive portfolio of products and services, including BacLite Technology and BacLite MRSA.
Rapid system for microbial detection and antibiotic sensitivity testing.
5-hour test for detecting MRSA from clinical swabs.
Investors in Acolyte Biomedica
Acolyte Biomedica has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include 3M.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
3M is recognized as a global leader in industrial innovation. | 1902 | 3m.com | United States |
Investor details for Acolyte Biomedica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Acolyte Biomedica
2 dated milestones of Acolyte Biomedica across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Acolyte Biomedica is founded.
- Exit Acquired by 3M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Acolyte Biomedica
Acolyte Biomedica was founded in 2000.
Acolyte Biomedica is headquartered in Salisbury, United Kingdom. It is registered at Salisbury, Wiltshire, United Kingdom.
Acolyte Biomedica has 16 employees.
Acolyte Biomedica was established in 2000 and is headquartered in Salisbury, United Kingdom. Focus is placed on the biomedical sector, where diagnostic systems for identifying infections are created. Proprietary BacLite technology is utilized to enable antibiotic susceptibility testing and micro-organism identification directly from clinical samples. Operations center on advancing infectious disease diagnostics to support clinical decision-making in healthcare settings.
Acolyte Biomedica offers BacLite Technology and BacLite MRSA.
Acolyte Biomedica has 1 investor. Key investors include 3M.
Acolyte Biomedica operates through Acolyte Biomedica Limited.
Yes. Acolyte Biomedica was acquired by 3M in February 2007.